Lapatinib, a dual HER1/HER2 tyrosine kinase inhibitor, augments basal cleavage of HER2 extracellular domain (ECD) to inhibit HER2-driven cancer cell growth

2010 ◽  
Vol 226 (1) ◽  
pp. 52-57 ◽  
Author(s):  
Alejandro Vazquez-Martin ◽  
Cristina Oliveras-Ferraros ◽  
Silvia Cufí ◽  
Sonia Del Barco ◽  
Begoña Martin-Castillo ◽  
...  
Keyword(s):  
Cell Growth ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cancer Cell ◽  
Kinase Inhibitor ◽  
Extracellular Domain ◽  
Cancer Cell Growth ◽  
Her2 Tyrosine Kinase Inhibitor

Effects of the Tyrosine Kinase Inhibitor Imatinib on Neuroendocrine Tumor Cell Growth

Digestion ◽  
2005 ◽  
Vol 71 (3) ◽  
pp. 131-140 ◽  
Author(s):  
Brigitte Lankat-Buttgereit ◽  
Dieter Hörsch ◽  
Peter Barth ◽  
Rudolf Arnold ◽  
Silke Blöcker ◽  
...  
Keyword(s):  
Cell Growth ◽  
Tyrosine Kinase ◽  
Tumor Cell ◽  
Tyrosine Kinase Inhibitor ◽  
Neuroendocrine Tumor ◽  
Kinase Inhibitor ◽  
Tumor Cell Growth

scholarly journals Role of Hepatic Transporters in the Disposition and Hepatotoxicity of a HER2 Tyrosine Kinase Inhibitor CP-724,714

2009 ◽  
Vol 108 (2) ◽  
pp. 492-500 ◽  
Author(s):  
Bo Feng ◽  
Jinghai J. Xu ◽  
Yi-An Bi ◽  
Rouchelle Mireles ◽  
Ralph Davidson ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Hepatic Transporters ◽  
Her2 Tyrosine Kinase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document